U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07449741) titled 'Phase I Study of HXN6005 in Adult Healthy Participants' on Feb. 26.
Brief Summary: The goal of this clinical trial is to evaluate the safety, tolerability, pharmacokinetic characteristics and pharmacodynamics of HXN6005 in Healthy Participants.
Researchers will compare HXN6005 to a placebo (a look-alike substance that contains no drug).
Participants will take a single dose of HXN6005 or placebo on Day 1, and visit the clinic for followup and tests per the protocol scheme.
Study Start Date: April 27
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteers (HV)
Intervention:
DRUG: HXN6005
participants will receive a single su...